Terms ending in 2033
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,394,282 | Pyrazole Carboxamides as Janus Kinase Inhibitors In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,573,811 | Method for Preparation of Aluminum Hydroxyphosphate Adjuvant In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,433,621 | Substituted Pyridine and Pyrimidine Derivatives and Their Use in Treating Viral Infections In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,428,784 | Methods for Increasing N-Glycan Occupancy and Reducing Production of Hybrid N-Glycans in Pichia Pastoris Strains Lacking ALG3 Expression In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,301,929 | Substituted Biaryl Derivatives and Methods of Use Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,505,730 | Mineralocorticoid Receptor Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,388,394 | Vaccines Against Clostridium Difficile Comprising Recombinant Toxins In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,290,453 | Quinolines and Aza-Quinolines as CRTH2 Receptor Modulators In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 10,577,316 | Process for Making Beta 3 Agonists and Intermediates In force · High confidence | Merck Sharp & Dohme Corp. | In force | High confidence | |
| US 9,073,930 | Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 158 more term ends in 2033 · Pro | |||||
10 of 168 patents shown. Soonest term end first, then patent number.
Pro members see all 168.
151 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.